MGLL and Sepsis: However, effective therapeutic strategies for sepsis-associated liver injury (SALI) remain limited.<h4>Methods</h4>In this study, we investigated the protective effects of MAGL-18c, a novel monoacylglycerol lipase (MAGL) inhibitor, on lipopolysaccharide (LPS)-induced SALI.